Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis

BACKGROUND: In patients with end stage renal disease and atrial fibrillation (AF), undergoing chronic dialysis, direct oral agents are contraindicated and warfarin does not fully prevent embolic events while increasing the bleeding risk. The high hemorrhagic risk represents the main problem in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Genovesi, Simonetta, Porcu, Luca, Slaviero, Giorgio, Casu, Gavino, Bertoli, Silvio, Sagone, Antonio, Buskermolen, Monique, Pieruzzi, Federico, Rovaris, Giovanni, Montoli, Alberto, Oreglia, Jacopo, Piccaluga, Emanuela, Molon, Giulio, Gaggiotti, Mario, Ettori, Federica, Gaspardone, Achille, Palumbo, Roberto, Viazzi, Francesca, Breschi, Marco, Gallieni, Maurizio, Contaldo, Gina, D’Angelo, Giuseppe, Merella, Pierluigi, Galli, Fabio, Rebora, Paola, Valsecchi, Mariagrazia, Mazzone, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881969/
https://www.ncbi.nlm.nih.gov/pubmed/32535831
http://dx.doi.org/10.1007/s40620-020-00774-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881969/
https://www.ncbi.nlm.nih.gov/pubmed/32535831
http://dx.doi.org/10.1007/s40620-020-00774-5

Ejemplares similares